Spinal Cord Stimulator Lawsuits by Manufacturer
Updated November 2, 2026. There is no single spinal cord stimulator lawsuit. The JPML refused to create one industry-wide MDL, so the manufacturer of your device determines which court hears your case and what it faces. This page compares Boston Scientific, Abbott, Nevro, and Medtronic side by side.
Key Takeaways
- Three MDLs exist, one each for three manufacturers: MDL-3181 (Boston Scientific), MDL-3194 (Abbott) and MDL-3195 (Nevro), the last two created by the JPML on October 2, 2026; Medtronic has none
- The JPML refused an industry-wide MDL because the manufacturers are not alleged to have acted in concert
- Abbott (2023) and Boston Scientific (2026, unused Infinion CX leads) have Class I recalls; Nevro has no classified recall at all; Medtronic has the most recalls
- The manufacturer of your device determines which court hears your case
- There is no verdict and no settlement against any manufacturer
Side-by-side comparison
| Manufacturer | MDL status | Petition | Device models | FDA recall history | Key ruling |
|---|---|---|---|---|---|
| Boston Scientific | MDL-3181 (C.D. Cal., Judge Staton) | Already centralized | WaveWriter, WaveWriter Alpha, Precision Montage, Spectra WaveWriter | Class I removal of unused Infinion CX leads (2026; implanted leads not affected); Class II WaveWriter Alpha recall (2024) | Sales-rep theory pleaded in every complaint; motions to dismiss due Nov 20, 2026; first MDL preemption ruling awaited |
| Abbott (St. Jude) | MDL-3194 (N.D. Ill., Judge Jenkins) | Granted October 2, 2026 (petition filed June 22, 2026); 27 pending in the November 2026 JPML report | Proclaim XR, Proclaim Plus, Proclaim DRG, Eterna | Class I recall (July 2023, 155,028 devices); Class II in 2024 and 2025 | Earlier centralization denial was a Section 1407 technicality, not a merits ruling |
| Nevro (with Globus Medical) | MDL-3195 (N.D. Cal., Judge Gilliam) | Granted October 2, 2026 (petition filed June 26, 2026); 24 pending in the November 2026 JPML report; initial status conference Dec 18, 2026 | Senza, Senza II, Senza Omnia, HFX iQ | No FDA-classified recall on record; 2,478 MAUDE reports (Jan 2024 to Jul 2026) | DiToto (plaintiff-favorable, May 2026) vs Greene (dismissed) and Yusnukis (dismissed; request to amend pending) |
| Medtronic | None | None | Intellis, Vanta, Inceptiv, Restore | Highest recall count (19 events / 23 product records since 2020); no Class I claimed | Schiltz order (July 14, 2026), the most consequential SCS ruling to date |
Device lists are drawn from manufacturer product lines and reporting, not from a court exhibit; the JPML transfer order names no specific models. Recall and MAUDE figures are from FDA databases. There is no verdict or settlement in the tort.
Why the split matters
The single most misreported fact in this tort is that there is one spinal cord stimulator lawsuit. There is not. When the JPML created MDL-3181 on June 5, 2026, it centralized only the Boston Scientific cases and expressly declined to create an industry-wide MDL, reasoning that the plaintiffs do not allege the manufacturers acted in concert and that each device line has its own regulatory history. On October 2, 2026, after its September 24 hearing session, the Panel created separate MDLs for Abbott (MDL-3194, Northern District of Illinois, Judge Lindsay C. Jenkins) and Nevro (MDL-3195, Northern District of California, Judge Haywood S. Gilliam, Jr.), again keeping each manufacturer apart and declining to send either to the judge handling Boston Scientific. The result is three separate MDLs plus Medtronic with none, summarized above, and the practical consequence is that the manufacturer of your device decides where your case goes.
One fact applies across all four: the filing deadline. The July 14, 2026 Schiltz order applied one-year state limitations periods and started the clock when a patient was advised to turn the device off or developed dramatic new symptoms, not at explant. That analysis will not apply in every state, but it makes the timeline more urgent than the two-to-four-year windows advertised on many firm pages, regardless of manufacturer.
Frequently Asked Questions
Which spinal cord stimulator lawsuits exist?
Why isn’t there one MDL for all spinal cord stimulator manufacturers?
Does the manufacturer determine where my case goes?
Have there been any settlements or verdicts against any manufacturer?
Sources & References
7 sources cited• JPML transfer order creating MDL-3181 (June 5, 2026) and the denial of an industry-wide MDL
• JPML Hearing Session Order (filed August 14, 2026) setting the Abbott and Nevro centralization motions for the September 24, 2026 hearing session
• JPML Transfer Orders, MDL No. 3194 (Abbott) and MDL No. 3195 (Nevro), October 2, 2026 (September 2026 hearing session)
• FDA recall notice, Boston Scientific Infinion CX leads (Class I; September 3, 2026); MDL-3181 Pretrial Orders No. 5 and No. 6; MDL-3195 Pretrial Order No. 1
• FDA Medical Device Recall Database and MAUDE Database for each manufacturer
• DiToto v. Nevro (D. Md., May 2026); Yusnukis and Greene dismissals
• Schiltz order, District of Minnesota (July 14, 2026)
• Judicial Panel on Multidistrict Litigation: November 2026 MDL statistics
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content.
Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.